Table 2.

Quantitative determination (μg/g FW) of myo-inositol, galactinol, and raffinose.

Sample	Metabolite (μg/g FW)
	Myo-inositol	Galactinol	Raffinose
FD-H	10.8 ± 0.8 bcdef	nd	1.8 ± 0.3 a
FD-RS	10.2 ± 0.3 abcd	nd	2.0 ± 0.1 a
FD-CS	11.9 ± 0.4 cdefg	0.6 ± 0.0 ab	2.9 ± 0.4 a
FD-CS21	9.7 ± 0.7 abc	1.2 ± 0.3 c	9.7 ± 2.9 b
FD-CS21+RS	10.1 ± 0.4 abcd	nd	3.1 ± 0.2 a
R2-H	10.9 ± 1.1 bcd	nd	1.3 ± 0.1 a
R2-RS	11.1 ± 0.9 bcdef	nd	1.4 ± 0.1 a
R2-CS	12.0 ± 0.9 cdefg	0.5 ± 0.0 a	1.8 ± 0.2 a
R2-CS21	8.8 ± 0.5 ab	0.5 ± 0.1 a	12.0 ± 2.0 b
R2-CS21+RS	8.1 ± 0.8 a	nd	2.1 ± 0.2 a
SL-H	12.8 ± 0.9 cfgh	nd	1.3 ± 0.2 a
SL-RS	13.3 ± 0.8 fghi	nd	1.7 ± 0.1 a
SL-CS	12.0 ± 1.0 cdefg	0.6 ± 0.1 a	3.0 ± 0.2 a
SL-CS21	10.9 ± 0.3 bcd	0.6 ± 0.0 a	25.0 ± 1.4 c
SL-CS21+RS	10.5 ± 1.0 abcd	nd	2.4 ± 01 a
RG-H	12.0 ± 0.7 cdefg	nd	1.3 ± 0.1 a
RG-RS	15.0 ± 1.0 hij	nd	1.7 ± 0.1 a
RG-CS	13.7 ± 0.9 ghij	0.7 ± 0.2 ab	3.6 ± 0.6 a
RG-CS21	12.0 ± 0.6 cfghi	1.7 ± 0.3 d	39.5 ± 0.7 e
RG-CS21+RS	13.4 ± 1.1 fghi	nd	2.9 ± 0.4 a
EL-H	14.0 ± 0.2 ghij	nd	1.1 ± 0.1 a
EL-RS	15.8 ± 0.9 j	nd	1.5 ± 0.1 a
EL-CS	15.0 ± 1.0 ghij	0.9 ± 0.1 abc	2.3 ± 0.2 a
EL-CS21	14.8 ± 1.2 ij	0.8 ± 0.1 abc	26.0 ± 3.0 c
EL-CS21+RS	12.3 ± 0.5 defgh	nd	1.7 ± 0.1 a
LM-H	11.2 ± 0.7 cdef	0.5 ± 0.0 a	1.2 ± 0.0 a
LM-RS	9.9 ± 0.6 abcd	0.6 ± 0.0 a	1.7 ± 0.3 a
LM-CS	9.8 ± 0.9 abc	1.1 ± 0.1 bc	2.5 ± 0.2 a
LM-CS21	11.0 ± 0.8 bcd	2.3 ± 0.3 e	31.3 ± 1.4 d
LM-CS21+RS	10.4 ± 0.5 abcd	0.5 ± 0.0 a	2.6 ± 0.2 a

Values (± SD) represent the mean of five independent determinations with three technical repetitions each one. All metabolites were quantified by GC-MS using calibration curves, which were run in parallel. nd: not detected. Different letters within each parameter indicate statistically significant differences (p < 0.05).